EVOK EVOKE PHARMA INC Capital Structure Changes 8-K Filing 2024 - Warrant Amendments Evoke Pharma, Inc. amended agreements with Nantahala Capital Management to reduce the exercise price of certain warrants, expecting to raise approximately $2.4 million in gross proceeds from this and related warrant exercises.Get access to all SEC 8-K filings of the EVOKE PHARMA INC